High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy-Reference-Cited by-同舟云学术

High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy

Published:2012-05 Issue:5 Volume:23 Page:1151-1156
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bouvard B.,Hoppé E.,Soulié P.,Georgin-Mege M.,Jadaud E.,Abadie-Lacourtoisie S.,Petit Le Manac’h A.,Laffitte A.,Levasseur R.,Audran M.,Chappard D.,Legrand E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/5/1151/476091/mdr356.pdf

Reference35 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer;Howell;Lancet,2005

4. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17;Goss;J Natl Cancer Inst,2005

5. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Engl J Med,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey;Tumori Journal;2024-03-10

2. Modeling and simulation of bone cells dynamic behavior under the late effect of breast cancer treatments;Medical Engineering & Physics;2023-05

3. Low-Magnitude Mechanical Signals Combined with Zoledronic Acid Reduce Musculoskeletal Weakness and Adiposity in Estrogen-Deprived Mice;2023-03-13

4. Fracture risk and assessment in adults with cancer;Osteoporosis International;2022-12-13

5. Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer;Journal of Bone Oncology;2021-06